Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z


Division of Vector-Borne Infectious Diseases Dengue: Clinical Manifestations and Epidemiology

 
slide 7 of 12
 Back Menu Table of contents Next
 

Hypothesis on Pathogenesis of DHF (Part 2)

  • In a subsequent infection, the pre-existing heterologous antibodies form complexes with the new infecting virus serotype, but do not neutralize the new virus
In a subsequent infection with a different virus serotype, the pre-existing heterologous antibodies form complexes with the new virus, but these heterologous antibodies do not neutralize the new serotype.

Esta página en Español

Back | Menu | Next |

CDC Home | Search | Health Topics A-Z |

This page last reviewed February 13, 2002

Division of Vector-Borne Infectious Diseases |
National Center for Infectious Diseases |
Centers for Disease Control and Prevention |
P.O. Box 2087
Fort Collins, Colorado 80522

CDC Privacy Policy | Accessibility |